Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as …
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for OWL skewed neutral (4 of 6 scored calls).
AI-curated news influencing OWL price, sentiment, and trend
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as …
Bank advised some clients to cut exposure, hitting a fund it had been instrumental in setting up
Blue Owl Capital Inc has completed a deal to buy a portfolio of UK private hospitals from Malaysia’s Employees Provident …
Blue Owl’s HomeCourt Partners’ Fund acquired a minority stake in the Cleveland Cavaliers, the firm announced Monday.
Bloomberg's Sinead Cruise joins Scarlet Fu on "Bloomberg Real Yield." For the second straight quarter, two Blue Owl Capital private …
For the second straight quarter, two Blue Owl Capital Inc. private credit funds were hit with the industry’s largest redemption …
Multi-Provider AI Analysis